WallStreetZenWallStreetZen

NASDAQ: SXTC
China Sxt Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
China Sxt Pharmaceuticals earnings were -$8.9M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest SXTC earnings report on Sep 30, 2025 announced Q3 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Mar 31, 2025, SXTC reported annual earnings of -$3.3M, with 6.6% growth.

SXTC earnings history

Current Revenue
$184.0
Current Earnings
-$8.9M
Current Profit Margin
-4,820,590.8%

SXTC Return on Equity

Current Company
-50.3%
Current Industry
15%
Current Market
35.1%
SXTC's Return on Equity (-50.3%)... subscribe to Premium to read more.
High Return on Equity Performance

SXTC Return on Assets

Current Company
-30.9%
Current Industry
5.6%
SXTC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SXTC announces earnings.

SXTC Return on Capital Employed

Current Company
-41.06%
Current Industry
9.7%
SXTC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SXTC vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SXTC-$8.26M-$8.87MN/A-$2.13
SHPH-$10.64M-$10.71MN/A-$5.84
KALA-$30.62M-$35.84MN/A-$5.66
UPC-$2.92B-$3.67BN/A-$8.06
IMCC$3.59M-$2.79MN/AN/A
View Top Pharmaceutical Stocks

China Sxt Pharmaceuticals Earnings Reports & History FAQ

What were China Sxt Pharmaceuticals's earnings last quarter?

China Sxt Pharmaceuticals (NASDAQ: SXTC) reported Q3 2025 earnings per share (EPS) of N/A, up N/A year over year. Total SXTC earnings for the quarter were N/A. In the same quarter last year, China Sxt Pharmaceuticals's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy China Sxt Pharmaceuticals stock.

Is China Sxt Pharmaceuticals profitable or losing money?

As of the last China Sxt Pharmaceuticals earnings report, China Sxt Pharmaceuticals is currently losing money. China Sxt Pharmaceuticals's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$8.87 million, a 253.06% decrease year over year.

What was SXTC's earnings growth in the past year?

As of China Sxt Pharmaceuticals's earnings date in Q1 2026, China Sxt Pharmaceuticals's earnings has grown year over year. SXTC earnings in the past year totalled -$8.87 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.